StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CCLD

CareCloud, Inc.

CCLD Nasdaq Services-Prepackaged Software EDGAR ↗
$2.08
+0.03 +1.46%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$88.4M
Revenue (TTM) ⓘ
$129M
Net income (TTM) ⓘ
-$2.80M
EPS (TTM) ⓘ
$0.09
P/E ratio ⓘ
23.1
Dividend yield ⓘ
—
Free cash flow ⓘ
$23.8M
Cash ⓘ
$6.41M
Total assets ⓘ
$93.8M
Gross margin ⓘ
—
52-week range ⓘ
$2.02 – $3.85

AI briefing

from the latest 10-K, 10-Q and 8-K events

CareCloud, Inc. is a healthcare IT company providing AI-powered revenue cycle management, cloud-based software, and related services to healthcare providers across the U.S.

What they do

CareCloud provides technology-enabled revenue cycle management (RCM), cloud-based software (EHR, practice management, RCM Cloud, HealthLine, Marketware, Wellsoft, CareVue), and AI solutions (cirrusAI). It also offers medical coding, credentialing, claims clearinghouse, digital health, IT professional services, and medical practice management. Operations rely heavily on offshore employees in Pakistan and Sri Lanka.

Revenue drivers

  • Technology-enabled RCM services — End-to-end medical billing, eligibility, analytics, coding, credentialing, and claims clearinghouse; primary revenue source, often paired with software.
  • Cloud-based software — EHR, practice management, RCM Cloud, HealthLine, Marketware, Wellsoft, CareVue; SaaS subscriptions and related capabilities.
  • AI solutions — cirrusAI Suite including clinical decision support and virtual assistant; increasingly adopted by clients, part of growth strategy.

Recent performance

Q2 2026 revenue was $31.9M, up 16% from $27.4M in Q2 2025; GAAP net income was $1.1M vs $2.9M prior year. YTD revenue $63.2M vs $55.0M; GAAP net income $2.0M vs $4.9M. Adjusted EBITDA $5.9M in Q2 vs $6.5M prior year. Company reported ninth consecutive quarter of positive GAAP net income. Full-year 2025 revenue was $120.5M with net income of $10.8M.

Strategy

Investing in AI capabilities and acquisitions to drive growth; acquired Empower Healthcare & Compliance Partners for compliance and audit-defense entry. Completed full redemption of Series B Preferred Stock in May 2026. Focus on cross-selling across 40,000+ providers. Increased R&D spending on AI and interest expense from capital structure simplification. Expects these investments to enhance scalability and long-term margin expansion.

Risks

  • Offshore operations dependence — Most operations rely on ~3,300 employees in Pakistan and Sri Lanka; political unrest, sanctions, or trade restrictions could disrupt services and raise costs.
  • Integration and acquisition risk — Acquisitions like MAP App, Medsphere, RevNu, and Empower Healthcare may not integrate effectively, causing legal exposure or revenue loss.
  • Cybersecurity and data privacy — Handles sensitive patient data; a cyber-attack could harm operations and reputation, lead to regulatory penalties.
  • Retention and competitive pressure — Must retain clients and keep pace with AI-driven healthcare changes; failure could reduce revenue and market position.

Outlook

Management reaffirmed 2026 guidance: revenue $128-$132 million, adjusted EBITDA $29-$31 million, GAAP EPS $0.20-$0.23. They expect investments in AI and acquisitions to drive future growth and margin expansion while maintaining profitability.

Recent SEC filings

40 most recent
Annual, quarterly & current reports